Inactive Instrument
US Rare Earth Minerals Inc Share Price Other OTC
Stocks
US9034101082
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-15 | Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-15 | Bioxytran, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 3.46M 2.99M 2.75M 2.58M 4.83M 329M 4.91M 32.52M 12.68M 160M 12.99M 12.71M 554M | P/E Ratio 2024 |
-5.27x | P/E Ratio 2025 | -3.28x |
|---|---|---|---|---|---|
| Enterprise Value | 4.2M 3.63M 3.34M 3.13M 5.87M 399M 5.96M 39.48M 15.39M 194M 15.77M 15.43M 673M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
99.38% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Platt
CEO | Chief Executive Officer | 73 | 31/08/2018 |
Ola Soderquist
DFI | Director of Finance/CFO | 65 | 31/08/2018 |
Leslie Ajayi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dale Conaway
BRD | Director/Board Member | 71 | 01/11/2018 |
Alan Hoberman
BRD | Director/Board Member | 73 | 01/11/2018 |
David Platt
CHM | Chairman | 73 | 31/08/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.03% | +2.30% | +54.92% | +111.78% | 55.58B | |
| +2.72% | +3.06% | +53.28% | +47.85% | 43.47B | |
| +1.04% | +2.59% | -13.88% | -17.70% | 22.64B | |
| +1.21% | +2.65% | +0.01% | +396.87% | 20.96B | |
| +3.81% | -4.13% | +16.62% | -30.70% | 15.79B | |
| +0.15% | +0.50% | +9.10% | -40.04% | 15.3B | |
| -0.64% | +0.94% | +27.32% | +178.65% | 13.45B | |
| +5.27% | +6.41% | +21.05% | - | 11.74B | |
| +1.61% | +1.17% | +90.79% | +212.97% | 10.96B | |
| Average | +1.80% | +0.26% | +28.80% | +107.46% | 23.32B | |
| Weighted average by Cap. | +1.70% | +1.60% | +33.67% | +100.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.37M -2.04M -1.88M -1.76M -3.3M -225M -3.36M -22.24M -8.67M -109M -8.88M -8.69M -379M | -2.12M -1.83M -1.69M -1.58M -2.96M -202M -3.01M -19.95M -7.78M -98.22M -7.97M -7.8M -340M |
| Net Debt | 1.09M 941K 867K 811K 1.52M 104M 1.54M 10.23M 3.99M 50.38M 4.09M 4M 174M | 741K 640K 590K 552K 1.03M 70.41M 1.05M 6.96M 2.71M 34.27M 2.78M 2.72M 119M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
